Regeneron told CNN that they did not submit a higher bid ... I guess nothing much has changed. That said, Wojcicki was CEO when 23andMe had a massive data breach, which hardly inspires confidence.

That means Wojcicki’s nonprofit TTAM Research Institute will purchase “substantially all” of San Francisco-based 23andMe’s ...

Me Holding said Tuesday that a U.S. bankruptcy court has approved the sale of “substantially all” its assets to TTAM Research ...

Anne Wojcicki, founder and former CEO of 23andMe, will helm the company again after her nonprofit's purchase was approved.

A bankruptcy court this week approved the $305 million sale of genetics testing firm 23andMe to a nonprofit organization led ...

A nonprofit research institute backed by Anne Wojcicki, 23andMe’s co-founder and former CEO, has been pressing 23andMe to consider additional bids purportedly topping Regeneron’s $256 million ...

23andMe was set to sell itself in bankruptcy to Regeneron before former CEO Anne Wojcicki bid $305 million after the auction ended through her recently founded nonprofit TTAM Research Institute.

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection.

In September, all seven of 23andMe's independent directors resigned due to disagreement with CEO Anne Wojcicki over the "strategic direction" of the company. In March, Wojcicki stepped down, and ...